RECURSION PHARMACEUTICALS, INC. 4

Blake Borgeson sold 40,000 shares of Recursion Pharmaceuticals Class A Common Stock for about $158,500 under a Rule 10b5-1 plan.

On July 7, 2026, insider Blake Borgeson sold 40,000 shares of Recursion Pharmaceuticals, Inc. Class A Common Stock at a weighted average price of approximately $3.96 per share under a pre-arranged Rule 10b5-1 trading plan adopted on August 31, 2025, generating proceeds of roughly $158,500 and leaving him with beneficial ownership of 6,218,287 shares following the transaction. The sale was executed in multiple trades within a narrow price range of $3.95 to $4.00 per share, indicating an orderly disposition rather than a one-time block trade.

Filing Facts

CIK

1601830

Ticker

RXRX

Form

4

Source Type

fda

Accession

0001856094-26-000011

Alert Tier

6